Clinical Trial Update: Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is testing adaptive de-intensified radiotherapy guided by circulating tumor DNA in HPV-positive oropharyngeal cancer, and the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: RECRUITING